University of South Carolina

Scholar Commons
Theses and Dissertations
6-30-2016

Effects Of Cortisol Stress Response Patterns On Autism Related
Behaviors In Young Adult Males With Fragile X Syndrome And
Autism Spectrum Disorders
Sara M. Matherly
University of South Carolina

Follow this and additional works at: https://scholarcommons.sc.edu/etd
Part of the Psychology Commons

Recommended Citation
Matherly, S. M.(2016). Effects Of Cortisol Stress Response Patterns On Autism Related Behaviors In
Young Adult Males With Fragile X Syndrome And Autism Spectrum Disorders. (Master's thesis). Retrieved
from https://scholarcommons.sc.edu/etd/3456

This Open Access Thesis is brought to you by Scholar Commons. It has been accepted for inclusion in Theses and
Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
digres@mailbox.sc.edu.

EFFECTS OF CORTISOL STRESS RESPONSE PATTERNS ON AUTISM RELATED
BEHAVIORS IN YOUNG ADULT MALES WITH FRAGILE X SYNDROME AND
AUTISM SPECTRUM DISORDERS
by
Sara M. Matherly
Bachelor of Science
University of North Carolina at Chapel Hill, 2007

Submitted in Partial Fulfillment of the Requirements
For the Degree of Master of Arts in
School Psychology
College of Arts and Sciences
University of South Carolina
2016
Accepted by:
Jane E. Roberts, Director of Thesis
Kimberly Hills, Reader

Lacy Ford, Senior Vice Provost and Dean of Graduate Studies

© Copyright by Sara M. Matherly, 2016
All Rights Reserved

ii

ABSTRACT
Fragile X syndrome (FXS) and autism spectrum disorders (ASD) are
characterized by deficits in social interactions (reduced eye contact, topic preoccupation,
and social withdrawal) and maladaptive behaviors of anxiety, social withdrawal, and
restricted interests (Kau, Tierney, Bukelis, Stump, Kates, Trescher et al., 2004). Prior
research with individuals who have FXS has indicated that problem behaviors (i.e. social
withdrawal and inattention) were correlated with abnormal activation of the
hypothalamus-pituitary-adrenal axis (HPAA; Hessl, et. al., 2002); however, very few
studies have investigated physiological patterns and associations with social dysfunction
and restricted and repetitive behaviors for individuals with idiopathic ASD. The present
study investigated the role of cortisol stress response physiological indices on directly
observed social affect deficits, repetitive behaviors and overall autistic behaviors within
adolescent to young adult males with FXS compared to idiopathic ASD. The study
involved two related analyses: 1) examination of mean levels and modulation of salivary
cortisol levels in response to two days of assessments and 2) the investigation of the
relationship of social affect deficits, restricted and repetitive behaviors and overall
autistic behaviors to salivary cortisol stress responses. Adolescent males with FXS with
and without ASD demonstrated elevated pre-assessment cortisol levels on Day 1;
however, persistent elevation in cortisol stress response at the start of Day 2 was only
found in adolescent males with ASD (idiopathic and with FXS). The greatest modulation
of cortisol stress response was found in adolescent males with FXS-O on Day 1 with
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exact opposite findings on Day 2 with adolescent males with iASD demonstrating the
greatest modulation of cortisol stress response. Lastly, lack of modulation of cortisol
stress response on Day 2 was predictive of greater social affect deficits in adolescent
males with iASD. Adolescent males with iASD and FXS with ASD have distinct
neuroendrocrine profiles that differentiate them from FXS alone. Additionally, increased
physiological reactivity during testing sessions was associated with greater
restricted/repetitive behaviors regardless of genetic or diagnostic status. The results also
support a complex interplay of maladaptive cortisol modulation and association with
social affect deficits in young adult males with idiopathic ASD.
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CHAPTER 1
INTRODUCTION
Over the past few decades autism spectrum disorder (ASD) has emerged as a
pervasive neurodevelopmental disorder characterized by deficits in social
communication/interaction and restricted interests and repetitive behaviors across settings
(American Psychiatric Association, 2013). ASD presents early in childhood and affects
approximately 1 in 42 males in the United States (Centers for Disease Control and
Prevention, 2014). Additionally, more than half of individuals with ASD also have
intellectual disabilities (ID). Only 10% of individuals with ASD establish independence
in adulthood, highlighting the magnitude of research on traits to promote positive adult
outcomes as a significant public health priority (Bailey, Raspa, Holiday, Bishop, &
Olmsted, 2009; Hartley et al., 2011). The high prevalence of ASD with ID, heterogeneity
in ASD, and ultimate taxing of economic, societal and familial care systems illustrate the
need to understand pathophysiological mechanisms that may improve the identification
and treatment for this disorder.
Several studies have hypothesized that abnormal arousal modulation underlies
behavioral attributes seen in ASD (Gabriels et al., 2013; Klusek, Roberts, & Losh, 2015);
however, evidence is mixed likely due to varying behavioral phenotypes, intellectual
abilities and inclusion of females within samples (Bitsika, Sharpley, Agnew, &
Andronicos, 2015; Zinke, Fries, Kliegel, Kirschbaum, & Dettenborn, 2010). One
pathophysiological mechanism and biomarker for measuring abnormal arousal
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modulation of the hypothalamic-pituitary-adrenal axis (HPAA) is through salivary
cortisol. Cortisol is secreted by the HPAA in response to stress and provides a
pathophysiological mechanism to understand behaviors related to ASD. Patterns of
arousal dysregulation through cortisol response may represent stress vulnerability
resulting in the manifestation of core behavioral attributes. The relationship between
arousal dysregulation as measured by cortisol and ASD behaviors has not been examined
in idiopathic ASD populations with ID. The study of the relationship between
pathophysiological mechanisms and core ASD behaviors in these and syndromic
populations is important given the negative impact of the severity of these behaviors on
the quality of life of individuals with ASD.
1.1 CORTISOL AS INDEX OF PATHOPHYSIOLOGICAL FUNCTIONING
Although the etiology of ASD is not well understood evidence supports a genetic
basis that is heterogeneous and complex with gene-gene and gene-environment
interactions leading to the common behavioral phenotype associated with ASD
(Abrahams & Geschwind, 2008). The study of pathophysiological mechanisms helps
establish biological correlates of core behaviors related to ASD. Physiological factors
modulating stress are known to play an important role in social development and have
broad associations with pathology. Biomarkers of stress response illustrating allostatic
compensatory mechanisms which allow individuals to adapt to stress stimuli serve as
indices for stress vulnerability. A number of neurobiological mechanisms have been
postulated to account for social and emotional dysfunction in ASD. One such mechanism
is abnormal activation and functioning of the HPAA in the peripheral nervous system
(Bitsika et al., 2015; Gabriels et al., 2013; Hollocks, Howlin, Papadopoulos, Khondoker,
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& Simonoff, 2014). The HPAA stress response systems are measured through secretion
of cortisol (Foley & Kirschbaum, 2010). The HPAA involves complex feedback
mechanisms with the hypothalamus, pituitary, hippocampus, and frontal cortex in order
to regulate stress (Foley & Kirschbaum, 2010). The secretion of cortisol by the HPAA in
response to stress is adaptive; yet, chronic abnormal activation can lead to adverse effects
such as immune suppression and interference with memory and learning abilities
(McEwen, et. al., 1997; Sapolsky, 2000). Cortisol salivary markers of stress complement
behavioral assessments and allow for more comprehensive examination of the
presentation and underlying mechanisms related to observable behaviors. The inclusion
of biomarkers in intellectual disabilities can be particularly relevant given self-report and
parental-reports are limited in these populations. Further identification of physiological
patterns and the role of the HPAA stress response system on influencing core ASD
behaviors in idiopathic and syndromic groups may inform targets for assessment and
interventions.
1.2 PATHOPHYSIOLOGICAL FUNCTIONING IN IDIOPATHIC ASD
Hutt and colleagues (1964) first proposed that individuals with ASD may
experience physiological hyperarousal that is associated with avoidance of social
interactions and novel stimuli and presence of stereotypies. Furthermore, ASD has been
described as a disorder accompanied by increased arousal, stress and sensory sensitivity
(Corbett, Schupp, Levine, & Mendoza, 2009). However, evidence of physiological
dysregulation in idiopathic ASD is varied with hypo-responsiveness to environmental
social stressors and hyper-responsiveness to nonevaluative, social stressors such as
medical procedures (Taylor & Corbett, 2014). For example, previous research has not
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found differences of cortisol awakening response in children with high functioning ASD
when compared to typically developing controls (Zinke et al., 2010). Yet, diurnal
rhythms of cortisol among individuals with ASD have demonstrated significantly greater
variability than typically developing peers as well as elevation in cortisol levels following
exposure to novel stimuli (Corbett, Mendoza, Wegelin, Carmean, & Levine, 2007;
Corbett et al., 2009). Clear dysregulation of the diurnal rhythm in ASD has been
characterized by gradual decrease of cortisol levels over the course of sampling in the
morning followed by elevated levels in the evening (Corbett et al., 2007; Corbett et al.,
2009). Results suggest that chronic stress and situations characterized by unstable social
relationships in childhood have resulted in lower cortisol responsivity or hypocortisolism
in ASD (Corbett et al., 2009). Additional research indicated that individuals with ASD
who engaged in frequent repetitive or self-injurious behaviors have evinced higher as
well as lower cortisol levels than those who engage in little to no repetitive or stereotyped
behaviors, demonstrating conflicting results (Bitsika et al., 2015; Gabriels et al., 2013;
Lydon et al., 2015). Furthermore, relationships between cortisol and repetitive
stereotypies appear to be present in childhood, but dissipate in adolescence, possibly
resulting from reduction of these behaviors as individuals progress into adulthood
(Bitsika et al., 2015). Hypo-responsiveness to acute stress paradigms, such as the Trier
Social Stress Test for Children, with high functioning individuals with ASD
demonstrating the absence of physiological response or less reactivity relative to same
age peers (Taylor & Corbett, 2014). Yet, opposite patterns have been demonstrated in
response to nonsocial, threatening situations with heightened physiological responses to
medical procedures(Taylor & Corbett, 2014). In all, mixed evidence exists of positive as
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well as negative associations between cortisol stress response patterns and core traits of
ASD; illustrating a complex interplay between physiological mechanisms, stress and
behaviors. To date, no study has investigated the effect of cortisol stress response on
social interaction deficits, restricted interests/repetitive behaviors and overall core
behavioral attributes associated with ASD. Additionally, none of these studies used the
Autism Diagnostic Observation Schedule as an outcome measure to capture these
severity of these behaviors in individuals with idiopathic ASD. Further delineation is
needed to provide a comprehensive account of the interaction among HPAA regulatory
subsystem and these behavior in idiopathic ASD.
1.3 AUTISM SPECTRUM DISORDERS IN FRAGILE X SYNDROME
Fragile X Syndrome (FXS) is the most common known single gene cause of ASD
with up to 90% of males demonstrating symptoms associated with an ASD (Cohen et al.,
2005; Thurman, McDuffie, Kover, Hagerman, & Abbeduto, 2015). FXS is caused by a
trinucleotide expansion of Cytosine Guanine Guanine (CGG) polymorphism in the 5’
untranslated regulatory region of the Fragile X Mental Retardation-1 (FMR1) gene on the
X chromosome (Kaufmann & Reiss, 1999). Individuals with the presence of more than
200 CGG repeats are said to have the full mutation, which results in hypermethylation of
the FMR1 promoter and silences the transcription of the FMR1 gene. Full mutation FXS
affects approximately one in 4,000 males in the general population (Crawford, Acuña, &
Sherman, 2001). Additionally, RNA transcriptional silencing from hypermethylation of
the FMR1 gene results in diminished or absent production of the Fragile X Mental
Retardation Protein (FMRP). FMRP is thought to regulate protein synthesis at synaptic
sites of neurons and is essential for normal brain development (Schneider, Hagerman, &
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Hessl, 2009). As a result, full mutation FXS in males is characterized by mild to
moderate intellectual disabilities and a host of behavioral attributes such as attention
problems, hyperactivity, anxiety, and autism spectrum disorders (Bailey, Raspa, Olmsted,
& Holiday, 2008; Cordeiro, Ballinger, Hagerman, & Hessl, 2011; Cornish, Cole, Longhi,
Karmiloff-Smith, & Scerif, 2013; Roberts et al., 2009).
Previous studies using the Autism Diagnostic Observation Schedule (ADOS) or
the Autism Diagnostic Interview-Revised (ADI-R) indicate prevalence estimates with
67% to 74% of males with FXS meeting criteria for an ASD (Clifford, Dissanayake, Bui,
Huggins, Taylor, & Loesch, 2007; Hall, Lightbody, & Reiss, 2008). Subsequent research
has focused on differentiating ASD in FXS from other related disorders. These findings
suggest that sustained poor eye contact and social avoidance throughout interactions,
social indifference, reduced nonverbal behavior, and social withdrawal appear to be
distinctly specific to individuals with FXS and ASD (fxASD) (Kau et al., 2004;
Kaufmann et al., 2004; Budimirovic et al., 2006; Roberts et al., 2007; Hessl, Glaser,
Dyer-Friedman, & Reiss, 2006). Additionally, robust findings in several previous studies
illustrate a negative relationship between IQ and ASD symptomatology in FXS with
lower IQ scores associated with greater severity of ASD behaviors on a variety of
measures (Bailey, Hatton, Skinner, & Mesibov, 2001; Hall, Lightbody, Hirt, Rezvani, &
Reiss, 2010; Thurman, McDuffie, Kover, Hagerman, & Abbeduto, 2015b). Furthermore,
reduced FMRP is thought to disrupt autism susceptibility genes, lowering the threshold of
interacting genetic, physiological and environmental factors that result in ASD within
FXS. Thus, FXS provides a more straightforward genetic context for deciphering the
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development and trajectories of core behavioral features associated with ASD in
comparison to multifactorial, idiopathic populations (Thurman et al., 2015).
1.4 PATHOPHYSIOLOGICAL FUNCTIONING IN FRAGILE X SYNDROME
Elevated levels of baseline or pre-social cortisol have been found in children who
have FXS (David Hessl, Glaser, Dyer-Friedman, & Reiss, 2006; Wisbeck et al., 2000).
Furthermore, suppressed cortisol regulation accounted for a significant amount of
variance in maladaptive behaviors, such as withdrawal, and social and attention deficits,
of children with FXS when compared to unaffected, typically developing siblings (Hessl
et al., 2002; Hessl et al., 2006). Thus, elevated baseline/pre-social and suppressed
regulation of HPAA responses of cortisol are correlated with social and emotional
dysfunction in FXS with the most frequent impairments presenting as extreme shyness,
social withdrawal, social anxiety and ASD (Roberts, Clarke, Alcorn, Carter, Long, &
Kaufmann, 2009). Of particular note, Hall and colleagues (2008) measured salivary
cortisol at four approximate time points during one day of evaluation including prebreakfast (8 am), pre-ADOS-G (3 pm), pre-dinner (5 pm) and pre-bedtime (9 pm).
Interestingly, a negative relationship was found between ADOS-G total score and preADOS cortisol levels in males with FXS. This indicates that males with lower cortisol
levels prior to ADOS-G administration demonstrated greater observable autistic
behaviors (Hall, Lightbody, & Reiss, 2008). These studies indicate that abnormal
activation of the HPAA may predict severity of autistic behaviors in FXS and differ
across environmental settings of stress.
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1.5 CURRENT STUDY AIMS
The purpose of this study is to examine the pattern of physiological stress
responses within FXS (with (fxASD) and without ASD (FXS-O)) and idiopathic ASD
(iASD) and how these physiological indicators mediate autistic related behaviors within
these populations. Behavioral phenotypes of social gaze avoidance, patterns of
withdrawal, social and nonverbal communication deficits are also prevalent in individuals
with idiopathic ASD; however, no study to our knowledge has yet examined the
differences in pathophysiological and environmental mechanisms related to stress in
individuals with idiopathic ASD. Direct between-group comparisons of physiological
patterns within individuals with FXS and idiopathic ASD are needed to assess similarities
and differences in symptomatology. Additionally, results highlighting the role of autism
symptomatology measured continuously will capture the effect of physiological
processes on dimensional aspects of behaviors. This will be of particular utility in FXS
due to significant behavioral presentations associated with ASD, which influences
increased rates of ASD diagnoses in this population. Knowledge regarding the
neuroendocrine and physiological basis of FXS and strong phenotypic overlap with ASD
allow for differentiation of specific phenotypes associated with FMR1 genetic variability.
Prior research has investigated HPAA responses, modulation of stress levels, and
relationships with physiological mechanisms and behavioral phenotypes in males with
FXS, but no comparisons exist in the literature that include males with idiopathic ASD.
Although review of literature is illustrating subtle differences in neurobiological
mechanisms underlying behaviors associated with ASD in FXS and idiopathic
populations (Abbeduto, McDuffie, & Thurman, 2014). This research study aims to
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address: 1) Do cortisol stress response patterns (pre-assessment or change) differ between
idiopathic ASD and FXS with and without ASD on Days 1 and 2 of evaluation and 2) do
cortisol stress response levels predict social affect deficits, restricted/repetitive behaviors,
or overall autistic behaviors in males with idiopathic ASD and FXS with and without
ASD?
The overarching purpose of the present study is to examine similarities and
differences in HPAA stress response patterns in adolescents with FXS (with and without
ASD) compared to idiopathic ASD and how these neuroendocrine determinants predict
autistic behaviors. It is hypothesized that males with FXS (with and without ASD) will be
differentiated from males with idiopathic ASD by their elevated pre-assessment cortisol
levels and reduced change cortisol rates (subtracting pre-assessment from postassessment cortisol levels). Furthermore, it is hypothesized that elevated pre-assessment
cortisol levels and decreased HPAA regulation (change) of stress responses will be
strongly associated with autism related behaviors, such as greater social affect deficits
and presence of repetitive behaviors in males with FXS, unlike idiopathic ASD,
demonstrating differences in physiological pathways.
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CHAPTER 2
METHODS
2.1 PARTICIPANTS
Subjects included 69 adolescent males participating in a larger longitudinal, crosssite study on language and factors that impact the transition into adulthood for males with
fragile X syndrome (FXS) and idiopathic ASD (iASD). Males with FXS had the full
mutation of the FMR1 gene (> 200 CGG repeats) which was confirmed through genetic
reports within the study. Idiopathic autism status was confirmed through educational and
diagnostic reports as well as genetic testing records which ruled out known genetic
disorders associated with autism, such as FXS. All participants were between 15 to 22
years old, verbally communicative (minimum combination of at least 3 words), spoke
English as their primary language, and lived with their biological parents during
enrollment in the longitudinal study. Despite attempts to match groups on nonverbal
intellectual abilities, participants with iASD had slightly higher nonverbal IQs,
particularly when compared to fxASD participants; see Table 2.1 below.
Adolescent males with FXS and iASD were recruited through various agencies
including the South Carolina Department of Disabilities and Special Needs (SC DDSN),
the Research Participant Registry Core of the Carolina Institute for Developmental
Disabilities (CIDD) at the University of North Carolina at Chapel Hill (UNC), local
South Carolina parent support groups, and a previous participant pool out of the
University of California at the Davis M.I.N.D. Institute. Institutional review boards at
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USC-Columbia and U.C. Davis approved all study protocols. All data consisted of
findings from each participant’s first time of evaluation regardless of site location, as part
of the longitudinal, cross-site study. Each family was compensated for travel expenses
and provided $50 for their participation.
2.2 MEASURES
Characterization of Autism
ADI-R. The Autism Diagnostic Observation Schedule-Second Edition (ADOS-2;
(Lord et al., 2012) and ADI-R were administered to confirm and classify autism spectrum
disorders in adolescent males with FXS and iASD (fxASD, FXS-Only, iASD). Only
participants who met diagnostic criteria for an autism spectrum disorder on both the
ADOS-2 and ADI-R were classified as having an autism spectrum disorder (fxASD or
iASD). The Autism Diagnostic Interview-Revised (Lord, Rutter, & Le Couteur, 1994) is
a standardized, semi-structured parent interview that is comprised of 93 items which
capture a child’s communication abnormalities, social interaction difficulties, presence of
restricted and repetitive behaviors and developmental delays. Each item is rated on a
scale from 0 (within normal limits or absence of abnormal behaviors) to 3 (severely
delayed or presence of abnormal behaviors). On the first day of their son’s visit, the ADIR was administered and scored live by examiners who completed standard research
reliability (i.e., training with an independent ADI-R trainer). Participants met autism
spectrum criteria if they scored at or above cutoffs in four domains including
communication, social interaction, restricted and repetitive behaviors, and developmental
delays and concerns.
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ADOS-2. The ADOS-2 consists of a series of semi-structured interview and play
opportunities between an examiner and a participant, allowing for the observation of
developmentally appropriate and inappropriate responses to these social exchanges. All
examiners completed research reliability in order to standardize administration and
scoring (i.e., reliable with an independent ADOS trainer). All administrations were
scored live by the examiners, then reliability was completed by one of the research
reliable staff who scored the administration from video and was blind to diagnostic
group. Interrater reliability was conducted as participants were randomly selected for
percent agreement, which was found to be moderately strong at 79% from the MIND and
71% from USC on the algorithm items. The ADOS-2 (Lord et al., 2012) was used as a
continuous measure of social affect deficits, restricted and repetitive behaviors, and
overall autistic traits (Gotham, Pickles, Lord, 2009). The ADOS-2 has also been reliably
used as an outcome measure with children who have ASD (Aldred, Green, & Adams,
2004; Charman et al., 2005) and a measure of autism symptomatology in individuals with
syndromic and idiopathic ASD (Hustyi, Hall, & Reiss, 2014; Oakes, Kover, & Abbeduto,
2012; Thurman et al., 2015b). Raw scores for social affect deficits, repetitive behaviors,
and overall autistic behaviors were used as dependent variables in analyses.
Cognitive Measure
Leiter-R. Nonverbal intellectual ability (IQ) was examined using the growth
composite scores of the Leiter International Performance Scale- Revised (Leiter-R; Roid
& Miller, 1997). The Leiter-R is a brief, standardized measure of nonverbal intellectual
ability for individuals ranging from 2 to 21 years of age. Overall, the Leiter-R was
normed on a large, representative sample of adolescents and young adults with inclusion
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of 123 individuals (63.4% male) with mild to severe cognitive delays, yielding high rates
of reliability for the brief IQ screener for individuals from 11 to 20 years of age (r=0.89;
Roid & Miller, 1997). The Visual Reception Battery subtests of Figure Ground, Form
Completion, Sequential Order, and Repeated Patterns have shown consistent internal
consistency reliability (α=0.65-0.86). Nonverbal mental age growth composite scores
from the Leiter-R Brief IQ were used to illustrate levels of intellectual ability in males
with iASD and FXS. Growth composite scores provided an estimate of absolute
performance on an equal-interval scale unlike raw or age equivalent scores. Growth
composite scores are also less susceptible to flooring effects than standard scores when
measuring intellectual ability within individuals with cognitive disabilities.
Cortisol Stress Response to Social Challenges
To study potential Hypothalamic-Pituitary-Adrenal Axis (HPAA) abnormalities
and its relationship to behaviors in iASD and FXS (with and without ASD), two samples
of salivary cortisol were taken for each participant on both days to characterize the
groups with attempts to match social testing stress. The first cortisol sample, “preassessment cortisol,” was taken within 15 minutes of the onset of the evaluation to
demonstrate pre-social challenge cortisol levels. The second cortisol sample, “postassessment cortisol,” was taken at the end of all evaluations to depict cortisol levels after
social challenges during the day. Pre-assessment cortisol was subtracted from postassessment cortisol levels which served as a measurement of stress regulation to assist
with interpretation of the participants’ physiological response to social challenges (ie.
testing throughout the day).
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Cortisol samples were collected using a salivette (oral cotton swab), which soaked
in a participant’s mouth for approximately 1 minute. Participants were asked to avoid
consuming citric acid and dairy products for at least 60 minutes prior to sampling in order
to reduce contamination and provide valid identification of physiological measurements.
All saliva samples were taken around the same time of day (pre-assessment: 9:00am on
Days 1 and 2, post-assessment: 2:30pm on Day 1 and 12:00pm on Day 2), then stored at 20 °C until analysis. Cortisol levels were determined employing a competitive solid
phase time-resolved fluorescence immunoassay with flouromeric end point detection
(DELFIA) using radioimmunoassay (Hessl et al., 2002). The intra-assay coefficient of
variation was between 4.0 to 6.7%, and the corresponding inter-assay coefficients of
variation were between 7.1 to 9.0%. Cortisol levels were measured in
micrograms/deciliters, data were log transformed for normality, and pre-assessment, postassessment and change cortisol levels were calculated from each day of direct
assessment.
2.3 PROCEDURES
Participants were tested in a quiet room in the laboratory at the University of
South Carolina or the University of California at the Davis M.I.N.D. Institute (UC
Davis). Testing sessions for the larger, parent study included two consecutive days of
evaluation that lasted approximately 5 hours on the first day and 3 hours on the second
day. All assessments were videotaped with a Panasonic AVCCAM AG-AC90
camcorder. This study includes selected measures from the overall testing evaluation in
which none of the assessments were designed to be stress inducing.
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2.4 DATA ANALYSIS
The primary goal of this study is to investigate neuroendocrine determinants of
stress response patterns and how these predict social deficits, repetitive
behaviors/restricted interests and overall autistic behaviors in adolescent males with FXS
(with and without ASD) and idiopathic ASD. All analyses were conducted using SPSS or
R version 3.0.3 (R Core Team 2013). Data were first analyzed for violations of
assumptions including homogeneity of variance, normality of residuals, and
multicollinearity. Cortisol samples were log transformed due to positive skewed
distribution in order to normalize the data to perform linear regression analyses. Missing
data cases (approximately 8%) were listwise deleted. Missing data was the result of
insufficient saliva to measure cortisol stress responses, exclusion of 1 administration and
scoring of the direct measure of autistic behaviors and lack of administration of a subtest
for 1 measure of intelligence. A Repeated Measure ANOVA was used to examine the
question of do cortisol physiological stress response patterns (pre-assessment and change)
differ in males with FXS-Only, fxASD and iASD across testing days. Secondly, multiple
regression analyses were then conducted to examine the predictability of autistic related
behaviors (social affect deficits, repetitive behaviors/restricted interests, and overall
autistic behaviors) within each diagnostic group. Follow up complementary analyses
were conducted to investigate the impact of autism behaviors on a continuous dimension
rather than segmenting groups categorically based on each aim.
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Table 2.1 Participant Demographics for Each Diagnostic Group
iASD (n=15)

fxASD (n=33)

FXS-O (n=21)

Chronological Age in
Years M (SD)
17.9 (2.9)
17.8 (2.2)
18.6 (2.7)
Nonverbal IQ Growth
Score1
481.3 (12.8)a
459.9 (13.6)b
467.2 (10.3)b
M (SD)
Nonverbal Brief IQ1
M (SD)
59.1 (23.1)a
38.3 (4.5)b
40.9 (6.5)b
Race %
Caucasian
80.0
84.8
85.7
African American
13.3
3.0
4.8
Asian
0
3.0
4.8
Multiracial
6.7
6.0
4.8
Other
0
3.2
0
Ethnicity %
Non-Hispanic
93.3
90.9
90.5
Hispanic
6.7
9.1
4.8
Not specify
0
0
4.8
Note. 1Leiter International Performance Scale- Revised. iASD= idiopathic autism spectrum
disorder; fxASD = fragile X syndrome and autism spectrum diagnosis; FXS-O = fragile X
syndrome only. Means in the same row with different superscripts differ significantly at p <.05.
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CHAPTER 3
RESULTS
Means and standard deviations for pre-assessment and change raw cortisol levels
(ug/dL) are presented in Table 3.1. Means and standard deviations of social affect,
repetitive behaviors/restricted interests, and overall autistic behaviors as captured by the
ADOS-2 are presented in Table 3.2. Repeated Measure ANOVAs were used to examine
cortisol stress response patterns (pre-assessment and change) across Day 1 and 2 of
assessments. Multivariate linear regression analyses were employed in order to examine
the interaction of cortisol stress response (pre-assessment and change) and diagnostic
group as predictors of directly observed social deficits, repetitive behaviors/restricted
interests, and overall autistic behaviors after controlling for nonverbal IQ.
3.1 CORTISOL STRESS RESPONSE PATTERNS IN YOUNG ADULT MALES
WITH iASD AND FXS
Pre-Assessment Cortisol Stress Response. A Repeated Measure ANOVA was
conducted to examine the effect of day and diagnostic group (iASD, fxASD and FXS-O)
on pre-assessment cortisol stress response patterns. The model was not statistically
significant when comparing pre-assessment cortisol stress response patterns across days,
F(1, 67)=.46, p=.50. Additionally, diagnostic group did not significantly predict changes
in cortisol stress response, F(2, 66)=1.57, p=.22. However, the interaction of day and
diagnostic group resulted in a statistically significant model, F(2, 66)=5.57, p=.006,
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ηp2=.144. Post hoc Repeated Measures ANOVA analyses found that adolescent males
with iASD had significantly lower rates of pre-assessment cortisol stress response on Day
1 than fxASD or FXS-O males. On Day 2 adolescent males with FXS-O were
approaching significant differences in pre-assessment cortisol levels when compared to
adolescent males with iASD and fxASD. Complementary analyses illustrated that autism
severity and nonverbal mental age did not predict pre-assessment cortisol on the 1st or 2nd
day of evaluation (p=.40 and p=.79). See Figure 3.1 and 3.2 for visual representations of
pre-assessment cortisol between diagnostic groups on Days 1 and 2 and Table 3.3 for
complete Repeated Measures ANOVA findings.
Change Cortisol Stress Response. Analyses were conducted to examine the
effect of day and diagnostic group on change cortisol stress response patterns. The model
was not significant when comparing change cortisol (baseline minus post-assessment)
patterns across days, F(1, 67)=.09, p=.77. However, the interaction of diagnostic group
and day on cortisol stress response patterns resulted in a significant model, F(2, 66)=7.23,
p=.001, ηp2=.18. Post hoc Repeated Measures ANOVA analyses found that FXS-O
adolescent males had significantly greater cortisol regulatory responses on Day 1 than
iASD and fxASD. On Day 2, adolescent males with FXS-O and fxASD had significantly
lower change cortisol responses than iASD males. See Figures 3.1 and 3.2 for visual
representation of change cortisol between diagnostic groups on Days 1 and 2 and Table
3.4 for complete Repeated Measures ANOVA findings. Complementary analyses
demonstrated that autism severity was approaching significance for predicting change
cortisol on day 1 (B=.03, p=.08), but not day 2 (B=.02, p=.44). Greater autism severity
predicted increased cortisol stress response from pre- to post-assessment levels following
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evaluation on day 1 only. Investigation of these effects based on genetic status found no
such relationship in participants with FXS. However, within males with iASD, greater
autism severity again was approaching significance for predicting increased cortisol
stress response from pre- to post-assessment levels on day 1 (B=.14, p=.08).
3.2 CORTISOL STRESS RESPONSE PREDICTING ASD RELATED
BEHAVIORS IN YOUNG ADULT MALES WITH iASD AND FXS
Pre-Assessment Cortisol Day 1 and Diagnostic Groups. A multivariate effect
for the combined dependent variables of social affect deficits, repetitive/restricted
behaviors and overall autistic behaviors in respect to the interaction of pre-assessment
cortisol on Day 1 and diagnostic group after controlling for nonverbal mental age was not
significant: λ = 0.985, F(4,62)=.236, p=.92. All linear regression models were significant
when investigating the impact of predictors (diagnostic groups, nonverbal IQ, preassessment cortisol on Day 1, and interaction of pre-assessment cortisol and diagnostic
groups) on each dependent variable with young adult males with FXS-O set as the
reference group: Social Affect: F(6, 62)=3.66, p=.004; Restricted/Repetitive Behaviors:
F(6, 62)=3.93, p=.002; Overall Autistic Behaviors: F(6, 62)=6.53, p<0.001. Greater
nonverbal IQ scores predicted lower social affect deficits (B= -.08, p=.04) and overall
ASD behaviors across all groups (B= -.11, p=.02). Pre-assessment cortisol stress
response on Day 1 and its interaction with each diagnostic group did not significantly
predict any of the dependent variables; see Table 3.5 for complete results.
Complementary analyses investigated the effect of pre-assessment cortisol on day 1 and
nonverbal mental age on behaviors related to autism after collapsing diagnostic groups
together. Similarly to above, only increased nonverbal mental age predicted reduced
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social affect deficits (B= -.07, p=.04), restricted/repetitive behaviors (B= -.04, p=.04) and
overall ASD behaviors (B= -.11, p=.01).
Pre-assessment Day 2 and Diagnostic Groups. A multivariate effect for the
combined dependent variables of social affect deficits, repetitive/restricted behaviors and
overall autistic behaviors in respect to the interaction of pre-assessment cortisol on Day 2
and diagnostic group after controlling for nonverbal mental age was also not significant:
λ = 0.96, F(4,62)=.70, p=.59. All linear regression models were significant when
investigating the impact of predictors (diagnostic groups, nonverbal IQ, pre-assessment
cortisol on Day 2, and interaction of pre-assessment cortisol and diagnostic groups) on
each dependent variable with young adult males with FXS-O set as the reference group:
Social Affect Deficits: F(6,62)=3.69, p=.003. Restricted/Repetitive Behaviors:
F(6,62)=3.74, p=.003. Overall ASD Behaviors: F(6,62)=6.48, p<.001. Greater nonverbal
IQ scores predicted lower social affect deficits (B= -.08, p=.049) and overall ASD
behaviors (B= -.12, p=.01) and was approaching significance for predicting lower
restricted, repetitive behaviors (B= -.04, p=.07) across all groups. Pre-assessment cortisol
stress response on Day 2 and its interaction with each diagnostic group did not predict
any of the dependent variables; see Table 3.6 for complete results. Complementary
analyses investigated the effect of pre-assessment cortisol on day 2 and nonverbal mental
age on behaviors related to autism after collapsing diagnostic groups together. As with
previous analyses, only increased nonverbal mental age predicted reduced social affect
deficits (B= -.07, p=.045), restricted/repetitive behaviors (B= -.04, p=.044) and overall
ASD behaviors (B= -.11, p=.01).
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Change Cortisol Day 1 and Diagnostic Groups. A multivariate effect for the
combined dependent variables of social affect deficits, repetitive/restricted behaviors and
overall autistic behaviors in respect to the interaction of change cortisol on Day 1 and
diagnostic group after controlling for nonverbal mental age was also not significant: λ =
0.90, F(4,62)=1.57, p=.19. All linear regression models were significant when
investigating the impact of predictors (diagnostic groups, nonverbal IQ, change cortisol
on Day 1, and interaction of change cortisol and diagnostic groups) on each dependent
variable with young adult males with FXS-O set as the reference group: Social Affect
Deficits: F(6,62)=3.83, p=.003; Restricted/Repetitive Behaviors: F(6,62)=4.48, p<.001;
Overall ASD Behaviors: F(6,62)=6.41, p<.001. Greater nonverbal IQ scores were found
to predict lower social affect deficits (B= -.08, p=.04) and overall ASD behaviors across
all groups (B= -.10, p=.02). Change cortisol stress response on Day 1 and its interaction
with each diagnostic group did not predict any of the dependent variables; see Table 3.7
for complete results. Complementary analyses, which collapsed diagnostic groups, found
that change cortisol on day 1 (B=1.45, p=.06) and nonverbal mental age were
approaching significance for predicting restricted and repetitive behaviors (B= -.03,
p=.06). Increased cortisol stress response from pre- to post-assessment levels were
associated with greater restricted and repetitive behaviors. Meanwhile, greater nonverbal
mental age was predictive of reduced restricted and repetitive behaviors. Finally, after
dichotomizing participants into those with increasing versus decreasing cortisol stress
responses throughout the day, males with increasing cortisol stress response patterns on
day 1 were approaching significance for predicting increased restricted and repetitive
behaviors (B=1.03, p=.06).
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Change Cortisol on Day 2 and Diagnostic Groups. A multivariate effect for
the combined dependent variables of social affect deficits, repetitive/restricted behaviors
and overall autistic behaviors in respect to the interaction of change cortisol on Day 2 and
diagnostic group after controlling for nonverbal mental age was also not significant: λ =
0.89, F(4,62)=1.90, p=.12. All linear regression models were again significant when
investigating the impact of predictors (diagnostic groups, nonverbal IQ, change cortisol
on Day 2, and interaction of change cortisol and diagnostic groups) on each dependent
variable with young adult males with FXS-O set as the reference group: Social Affect
Deficits: F(6,62)=4.91, p<.001; Restricted/Repetitive Behaviors: F(6,62)=3.69, p=.003;
Overall ASD Behaviors: F(6,62)=6.62, p<.001. Greater nonverbal IQ scores predicted
lower social affect deficits (B= -.07, p=.049) and overall ASD behaviors (B= -.11, p=.01)
and was approaching significance for predicting lower restricted, repetitive behaviors (B=
-.04, p=.069) across all groups. Additionally, a greater reduction in cortisol stress
response on Day 2 predicted lower social affect deficits (B= -10.67, p=.03) and was
approaching significance for predicting lower overall ASD behaviors (B= -9.68, p=.10)
in young adults males with iASD only. An interaction between change cortisol stress
response and a diagnosis of fxASD or FXS-O was not found; see Table 3.8 for complete
results. Complementary analyses were run which collapsed diagnostic groups. Similarly
to previous effects, only increased nonverbal mental age accounted for reduced social
affect deficits (B= -.07, p=.03), restricted/repetitive behaviors (B= -.03, p= .08) and
overall ASD behaviors (B= -.10, p=.01). Change cortisol stress response on day 2 was
not predictive of behaviors related to autism even after dichotomizing participants into
those with increasing compared to decreasing levels from pre- to post-assessment.
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Table 3.1. Raw Cortisol Stress Response Levels (ug/dL) for Males with iASD and FXS
Cortisol Levels by
Days
Pre-Assessment
M (SD)
Post-Assessment
M (SD)
Change
M (SD)
Pre-Assessment
M (SD)
Post-Assessment
M (SD)
Change
M (SD)

Day 1
iASD (n=15)

fxASD (n=33)

FXS-O (n=21)

5.00 (4.15)

8.08 (6.30)

6.61 (6.08)

4.61 (3.96)

5.76 (5.34)

3.22 (1.95)

0.40 (5.32)

2.31 (6.41)
Day 2

3.38 (5.70)

7.17 (5.03)

8.94 (18.18)

4.95 (3.56)

4.02 (3.96)

6.01 (4.58)

4.22 (2.63)

-3.16 (3.04)

-2.94 (15.26)

-0.73 (3.45)

Table 3.2. ASD Raw Scores for Young Adult Males with iASD and FXS

Social Affect Deficits
M (SD)
Repetitive Behaviors
M (SD)
Overall ASD Behaviors
M (SD)

iASD (n=15)

fxASD (n=33)

FXS-O (n=21)

9.00 (4.44)

9.97 (3.32)

5.81 (4.25)

3.47 (1.77)

3.97 (2.17)

1.81 (1.60)

12.47 (4.69)

13.94 (4.28)

7.62 (4.74)
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Pre-Assessment
Post-Assessment
Change
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5
3
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FXS-O

-3
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Figure 3.1. Day 1 Pre-Assessment, Post-Assessment and Change Cortisol Stress Response
Patterns in iASD and FXS Males

Pre-Assessment
Post-Assessment
Change

9

Raw Cortisol (ug/dL)

7
5
3
1
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fxASD

FXS-O

-3
-5

Figure 3.2. Day 2 Pre-Assessment, Post-Assessment and Change Cortisol Stress Response
Patterns in iASD and FXS Males
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Table 3.3. Repeated Measure ANOVAs of Pre-Assessment Cortisol Stress Response Patterns in
iASD and FXS Males with and without ASD
Pre-Assessment Cortisol
Source
Day
Day x Diagnosis
Error

SS
0.02
0.50*
2.99

df
1
2
66

MS
0.02
0.25
0.05

F
0.46
5.57*

Day 1
Diagnostic
Group

N

Mean

p
0.50
0.01

Day 2
SE

Mean

SE

iASD
15
5.00a
.098
7.17c
.087
b
fxASD
33
8.08
.066
8.94c
.059
FXS-O
21
6.61b
.083
4.95d
.074
Note. *p<.05. Pre-assessment cortisol is log transformed for normality.
Raw pre-assessment cortisol means are reported to demonstrate differences.
Means in the same column with different superscripts of a or b differ significantly at p <.05.
Means in the same column with different superscripts of c or d differ significantly at p <.10.

Table 3.4. Repeated Measure ANOVAs of Change Cortisol Stress Response Patterns in iASD and
FXS Males with and without ASD

Source
Day
Day x Diagnosis
Error

SS
0.008
1.23*
5.62

df
1
2
66

N

Mean

Change Cortisol
MS
0.008
0.62
0.09

F
0.09
7.23*

Day 1
Diagnostic
Group

p
0.77
0.001

Day 2
SE

Mean

SE

iASD
15
.40a
.083
3.16a
.078
a
fxASD
33
2.31
.056
2.94b
.178
FXS-O
21
3.38b
.071
.73b
.066
Note. *p<.05. Change cortisol is log transformed for normality.
Raw change cortisol means are reported to demonstrate differences.
Means in the same column with different superscripts of a or b differ significantly at p <.05.
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Table 3.5. Multivariate Linear Regression Results: Pre-Assessment Cortisol Levels on Day 1
Predicting Social Affect Deficits and Restricted and Repetitive Behaviors in iASD and FXS Males

Wilk’s λ

Multivariate Tests
df

F

p

η2

Nonverbal IQ

0.89

1

3.86*

0.03*

0.07

Group

0.66

2

7.04*

<0.01*

0.12

Pre-Assmt
Cortisol Day 1
Group x PreAssmt
Cortisol Day 1

0.94

1

1.82

0.17

0.02

0.96

4

0.24

0.92

0.02

Effect

Social Affect
Deficits
B (SE)
t
Intercept

Restricted/Repetitive
Behaviors
B (SE)
t

2.32*

13.44 (9.00)

1.49

FXS-O
(reference
group)
fxASD

41.99
(18.09)
--

--

--

3.42(2.48)

1.38

iASD

3.28(3.10)
-.08(.04)

Nonverbal IQ

Overall ASD
Behaviors
B (SE)
t
2.72**

--

55.43
(20.41)
--

2.73(1.23)

2.21*

6.15(2.80)

2.20*

1.06

1.46(1.54)

.95

4.74(3.50)

1.36

2.07*
-.42

-.03(.02)

-1.42

-.11(.04)

-2.46*

--

Pre-.91(2.18)
-1.19(1.09)
-1.10
-2.10(2.50)
-.86
Assessment
Cortisol Day 1
fxASD x
-.44(3.00)
-.15
.94(1.49)
.63
.49(3.38)
.15
Pre-Assmt
Cortisol Day 1
iASD x -1.06(3.21)
-.33
-.49(1.60)
-.31
-1.54(3.62)
-.43
Pre-Assmt
Cortisol Day 1
Note. *p<.05, **p<.001
Social Affect Deficits: R2=.189, F(6,62)=3.656, p<.05. Restricted/Repetitive Behaviors: R2=.205,
F(6,62)=3.925, p<.05. Overall ASD Behaviors: R2=.328, F(6,62)=6.529, p<.001.
Pre-assessment cortisol (ug/dL) is log transformed for normality.
Social Affect Deficits, Restricted/Repetitive Behaviors and Overall ASD Behaviors from the
Autism Diagnostic Schedule-2. FXS-O, fragile X syndrome – only, established as the reference
group within the multivariate regression model. fxASD, fragile X syndrome and autism spectrum
diagnosis; iASD, idiopathic autism spectrum diagnosis.
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Table 3.6. Multivariate Linear Regression Results: Pre-Assessment Cortisol Levels on Day 2
Predicting ASD Behaviors in iASD and FXS Males
Wilk’s λ

Multivariate Tests
df

F

p

η2

Nonverbal IQ

.88

1

4.02

.02

.11

Group

.66

2

6.99

<.001

.14

Pre-Assmt
Cortisol Day 2
Group x PreAssmt
Cortisol Day 2

.99

1

.34

.71

.01

.96

4

.70

.59

.004

Effect

Social Affect
Deficits

Intercept
FXS-O
(reference
group)
fxASD
iASD
Nonverbal IQ

Restricted/Repetitive
Behaviors

Overall ASD
Behaviors

B (SE)

t

B (SE)

t

B (SE)

t

41.58(19.31
)
--

2.15*

17.87(9.68)

1.85t

59.45(21.83)

2.72**

--

--

--

--

--

5.33(2.92)

1.82t

2.40(1.47)

1.64

7.73(3.31)

2.34*

8.05(3.40)

2.37*

4.17(1.71)

2.45*

12.23(3.85)

3.18**

-.08(.04)

-2.00*

-.04(.02)

-1.82t

-.12(.05)

-2.58*

Pre- -2.09(2.31)
-.90
-1.24(1.16)
-1.07
-3.33(2.62)
-1.27
Assessment
Cortisol Day 2
fxASD x 1.97(3.28)
.60
.41(1.64)
.25
2.38(3.71)
.64
Pre-Assmt
Cortisol Day 2
iASD x 4.84(4.16)
1.16
2.57(2.09)
1.23
7.41(4.70)
1.57
Pre-Assmt
Cortisol Day 2
Note. tp<.10, *p<.05, **p<.001
Social Affect Deficits: R2=.192, F(6,62)=3.685, p<.05. Restricted/Repetitive Behaviors: R2=.195,
F(6,62)=3.741, p<.05. Overall ASD Behaviors: R2=.326, F(6,62)=6.480, p<.001.
Pre-assessment cortisol (ug/dL) is log transformed for normality.
Social Affect Deficits, Restricted/Repetitive Behaviors and Overall ASD Behaviors from the
Autism Diagnostic Schedule-2. FXS-O, fragile X syndrome – only, established as the reference
group within the multivariate regression model. fxASD, fragile X syndrome and autism spectrum
diagnosis; iASD, idiopathic autism spectrum diagnosis.
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Table 3.7. Multivariate Linear Regression Results: Change Cortisol Levels on Day 1 Predicting
ASD Behaviors in iASD and FXS Males
Wilk’s λ

Effect

Multivariate Tests
df

F

p

η2

Nonverbal IQ

.89

1

3.7

.03

.11

Group

.66

2

7.01

<.001

.17

Change
Cortisol Day 1
Group x
Change
Cortisol Day 1

.97

1

.88

.42

.03

.90

2

1.57

.19

.002

Social Affect Deficits

Restricted/Repetitive
Behaviors
B (SE)
t

Overall ASD
Behaviors
B (SE)
t

B (SE)

t

Intercept

41.53(17.43)

2.38*

12.87(8.57)

1.50

54.40(19.86)

FXS-O
(reference
group)
fxASD

--

--

--

--

--

--

4.39(1.28)

3.44**

1.49(.63)

2.37*

5.88(1.45)

4.04**

iASD

4.86(1.53)

3.18**

1.58(.75)

2.11*

6.44(1.74)

3.70**

Nonverbal IQ

-.08(.04)

-2.09*

-.02(.02)

-1.25

-.10(.04)

-2.37*

Change
Cortisol Day 1
fxASD x
Change
Cortisol Day 1
iASD x
Change
Cortisol Day 1

-2.64(2.72)

.97

1.58(1.34)

1.18

-1.05(3.10)

-.34

4.16(3.68)

1.13

-2.78(1.81)

-1.81

1.38(4.19)

.33

4.78(3.63)

1.32

.64(1.78)

.36

5.42(4.14)

1.31

2.74**

Note. tp<.10, *p<.05, **p<.001
Social Affect Deficits: R2=.200, F(6,62)=3.832, p<.05. Restricted/Repetitive Behaviors: R2=.235,
F(6,62)=4.475, p<.001. Overall ASD Behaviors: R2=.323, F(6,62)=6.412, p<.001.
Pre-assessment cortisol (ug/dL) is log transformed for normality.
Social Affect Deficits, Restricted/Repetitive Behaviors and Overall ASD Behaviors from the
Autism Diagnostic Schedule-2. FXS-O, fragile X syndrome – only, established as the reference
group within the multivariate regression model. fxASD, fragile X syndrome and autism spectrum
diagnosis; iASD, idiopathic autism spectrum diagnosis.
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Table 3.8. Multivariate Linear Regression Results: Change Cortisol Levels on Day 2 Predicting
ASD Behaviors in iASD and FXS Males
Multivariate Tests
Wilk’s λ

df

F

p

η2

Nonverbal IQ

.89

1

3.86

.03

.10

Group

.67

2

6.81

<.001

.17

Change
Cortisol Day 2
Group x
Change
Cortisol Day 2

.97

1

.92

.40

.03

.89

2

1.90

.11

.034

Effect

Social Affect
Deficits

Restricted/Repetitive
Behaviors

Overall ASD
Behaviors

B (SE)

t

B (SE)

t

B (SE)

t

Intercept

39.30(16.73)

2.35*

18.05(8.76)

2.06*

57.28(19.64)

2.92**

FXS-O
(reference
group)
fxASD

--

--

--

--

--

--

3.75(1.06)

1.91(.55)

3.44**

5.65(1.24)

4.56**

iASD

1.01(1.88)

3.55*
*
.55

2.78(.99)

2.82**

3.80(2.22)

1.73t

-.07(.04)

-2.01*

-.04(.02)

-1.85t

-.11(.04)

-2.53*

Nonverbal IQ

Change
-.53(2.23)
-.24
1.26(1.17)
1.08
.73(2.62)
.28
Cortisol Day 2
fxASD x
1.78(3.20)
.56
-1.12(1.68)
-.67
.67(3.76)
.18
Change
Cortisol Day 2
iASD x -10.67(4.89) -2.17*
.99(2.57)
.37
-9.68(5.76)
-1.68t
Change
Cortisol Day 2
Note. tp<.10, *p<.05, **p<.001
Social Affect Deficits: R2=.257, F(6,62)=4.913 p<.001. Restricted/Repetitive Behaviors:
R2=.192, F(6,62)=3.685 p<.05. Overall ASD Behaviors: R2=.332, F(6,62)=6.622, p<.001.
Pre-assessment cortisol (ug/dL) is log transformed for normality.
Social Affect Deficits, Restricted/Repetitive Behaviors and Overall ASD Behaviors from the
Autism Diagnostic Schedule-2. FXS-O, fragile X syndrome – only, established as the reference
group within the multivariate regression model. fxASD, fragile X syndrome and autism spectrum
diagnosis; iASD, idiopathic autism spectrum diagnosis.
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CHAPTER 4
DISCUSSION
The current study included low functioning young adult males with FXS and
idiopathic ASD in order to examine differences in cortisol stress response patterns to a
series of language, cognitive, social, and experimental assessments and the mediating
effect of this pathophysiological mechanism on core traits of ASD, such as social affect
deficits, restrictive interests/repetitive behaviors and overall autistic behaviors. Data were
collected on two consecutive days in an effort to gain insight of stress regulation in
response to a novel testing environment and assessments and its predictive value on these
core behavioral features related to ASD. Detection of pathophysiological biomarkers can
facilitate intervention services through diagnosis and treatment of behavioral features
related to ASD.
4.1 SALIVARY CORTISOL PRE-ASSESSMENT AND CHANGE STRESS
RESPONSE PATTERNS IN iASD AND FXS
This study confirms previously-reported findings of higher initial stress responses
in FXS than idiopathic ASD to novel assessments with greater dysregulation in ASD
regardless of genetic status; yet, expands this literature to illustrate a complex interplay
between physiological processes, environment and behaviors in these populations. In
contrast to prior research, this study focused on pre-assessment and change cortisol stress
response across two days of testing. Two new findings emerge when examining
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physiological stress response patterns in FXS with and without ASD in comparison to
idiopathic ASD across two testing days. First, a significant interaction was found between
diagnostic group and testing day on pre-assessment and change cortisol stress response
on both days of evaluations. On the first day, males with FXS demonstrated significantly
elevated pre-assessment cortisol stress response compared to males with ASD regardless
of genetic status. Males with idiopathic ASD regulated significantly less throughout the
day than males with only FXS. Secondly, day 2 is marked with habituation to testing
settings in males with only FXS and a lack of habituation to settings with greater stress
response regulation in idiopathic ASD. Additionally, complementary analyses highlight
the maladaptive role of increased autism symptomatology on cortisol patterns, as
demonstrated by an increase in stress response from pre-to post-assessment on day 1 of
evaluations. Although this finding appears to only be present in males with idiopathic
ASD as no such relationship when examining specifically in FXS.
These findings support research that illustrates atypical autonomic activity and
reactivity in FXS, particularly to novel assessments and settings on Day 1. However,
habituation to stress was exhibited in FXS only males, demonstrating adaptive
physiological regulation which has not been reported in previous findings. Additionally,
variable cortisol stress response patterns have been demonstrated in idiopathic ASD with
typical cortisol awakening response; yet, significant variability in diurnal rhythms in
children with high functioning ASD( Corbett et al., 2007; Zinke et al., 2010). Variability
in HPA responsiveness has been exhibited in response to environmental settings with
findings of HPA hypo-responsiveness during social evaluative stressors, such as the Trier
Social Stress Test for Children, and hyper-responsive to unpleasant, benign social
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situations such as a blood draw procedure or MRI (Taylor & Corbett, 2014). Our results
support autonomic dysregulation in ASD, regardless of genetic status, with opposing
physiological reactions to testing sessions compared to FXS only males.
These results suggest that young adult males with FXS only and those with ASD
demonstrate distinctly opposing physiological stress response patterns. FXS is marked by
heightened pre-assessment cortisol patterns, unlike males with idiopathic ASD. However,
variable cortisol responses were found in ASD, regardless of genetic status, with
heightened levels on day 2 rather than day 1 of evaluation. While participants with
idiopathic ASD demonstrated the greatest regulation on day 2, these findings are
counterintuitive to typical physiological expectation as habituation effects to the
environment would be expected.
4.2 CORTISOL STRESS RESPONSE PREDICTING ASD RELATED
BEHAVIORS IN YOUNG ADULT MALES WITH iASD and FXS
In regards to the second aim, cortisol stress response levels did not predict social
affect deficits, restricted interests/repetitive behaviors or overall autistic behaviors in
young adult males with FXS regardless of ASD status; however, greater physiological
regulation on day 2 was predictive of lower social affect deficits in idiopathic ASD.
Collapsing diagnostic groups highlighted the deleterious effects of physiological stress
response from pre- to post-assessment on restricted and repetitive behaviors with
increasing levels associated with greater restricted and repetitive behaviors.
Unlike previous research in FXS, no associations were shown between cortisol
levels and social difficulties or overall ASD behaviors . Prior analyses examined the
predictive nature of cortisol levels in school age children with FXS, while this study

32

consisted of adolescents and young adult males, possibly explaining the lack of
association in the present study. Additionally, methodologies for measuring social,
emotional and behavioral problems differ across studies with only Hall and colleagues
(2008) use of the ADOS-G as an outcome measure. Hall and colleagues (2008) found a
significant negative association between ADOS-G total score and pre-ADOS salivary
cortisol samples in males with FXS with lower salivary cortisol levels prior to the
assessment correlated with greater autistic behaviors. This sample differs from the current
study with inclusion of children to adult males from 5 to 20 years of age, collection of
salivary cortisol across four time points in one day, and exclusion of the effects of
intellectual functioning on this relationship. These differences likely account for the lack
of similar findings between pre-assessment cortisol and overall autistic behaviors in
males with FXS found in the present study. Secondly, literature in ASD has focused on
associations between cortisol levels and repetitive, compulsive and self-injurious
behaviors (Bitsika et al., 2015; Gabriels et al., 2013; Lydon et al., 2015). Direct
associations have been found between stress and stereotypy in children with ASD;
however, directionality of these relationships has differed depending on population.
Furthermore, research supports a lack of association between stress and repetitive
behaviors in adolescence, which is upheld by the present study (Bitsika et al., 2015).
The present study expands this work illustrating the adaptive nature of
physiological regulation in ASD as demonstrated by reduced rates of social affect
deficits. Greater reduction in cortisol stress response was indicative of better social
communication and affect skills, but only in young adult males with idiopathic ASD.
Findings suggest that physiological regulation of stress in males with FXS is not
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associated with behaviors related to ASD as individuals progress into young adulthood;
however, physiological response may influence the severity of stereotypies or
restricted/repetitive behaviors as evidenced by a positive association between
physiological response and restricted behaviors after collapsing diagnostic groups.
4.3 LIMITATIONS
There were four main limitations in the study. First, cross-sectional approaches
were used to examine patterns of cortisol stress response and the predictive nature of this
pathophysiological mechanism on ASD symptomatology. Cross-sectional approaches
provide a snap shot of the relationships; thus, replication of this study will be needed to
cement these findings. The second and third limitations were the inclusion of only males
and individuals with low cognitive abilities (IQ less than 85). These results do not
generalize to females with FXS or idiopathic ASD or high functioning individuals.
Lastly, the current study utilized the ADOS-2 as a measure of autism symptomatology.
While the ADOS-2 is considered the ‘gold standard’ tool for directly measuring
behaviors related to ASD, it provides only one piece of a larger picture. Behaviors
captured by the ADOS-2 may actually be better explained by another comorbid
condition. This issue becomes problematic, particularly in FXS due to the increased risk
of numerous co-occurring conditions such as intellectual disability, attention problems
and anxiety which may influence behaviors captured during the ADOS-2 administration.
4.4 FUTURE DIRECTIONS AND CONCLUSIONS
Concerning future directions, it would be beneficial to examine core traits of ASD
across direct observation and parent reported measures. Inclusion of additional
observation and parent reported tools provides additional sources of information on ASD
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symptomatology and their association with physiological stress responses. Also, more
longitudinal research should be conducted to examine the persistence of stress response
patterns across the developmental trajectory into adulthood for males with FXS and
idiopathic ASD. Following participants throughout early adulthood would be informative
to the presentation of pathophysiological stress responses and ASD symptomatology and
how they may change during maturation.
The current study presents the first examination of cortisol stress response
patterns, one form of a pathophysiological biomarker, as indicators of concurrent ASD
symptomatology in young adult males with FXS with and without ASD compared to
males with idiopathic ASD. The results of the this study provide insight into possible
varying physiological stress responses in this population and the association of this
mechanism with social affect deficits found only in idiopathic ASD. Future studies
should continue to investigate the interplay of physiological and environmental
contributors to the ASD symptomatology in males with FXS and idiopathic ASD. The
identification of physiological dysregulation underlying core traits of ASD
symptomatology may contribute to strategies for diagnosis and treatment in this sample
as well as broader, non-ASD populations.
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